Literature DB >> 10487840

Activation of infiltrating cytotoxic T lymphocytes and lymphoma cell apoptotic rates in gastric MALT lymphomas. Differences between high-grade and low-grade cases.

M Guidoboni1, C Doglioni, L Laurino, M Boiocchi, R Dolcetti.   

Abstract

In this study, we have characterized infiltrating T lymphocytes from 13 low-grade and 17 high-grade primary gastric MALT lymphomas by immunohistochemistry, with particular regard to the presence, activation, and topographic distribution of cytotoxic effectors. Although the prevalence of CD4+ and CD8+ cells was similar in low- and high-grade lymphomas, higher numbers of TIA-1+ cytotoxic effectors were found in this latter group of cases (11.6 versus 7. 8%; P = 0.004). Activation of CD8+ cytotoxic T lymphocytes (CTLs) was significantly more pronounced in high- than in low-grade lymphomas, as shown by immunostaining for perforin (8.7 versus 4.0%; P = 0.001) and granzyme-B (GrB) (8.7% versus 3.0%; P < 0.0001). Of note, CD20/GrB double labeling showed that high-grade lymphomas carried a markedly higher content (about ninefold) of activated CTLs relative to the number of CD20+ lymphoma B cells (0.081 +/- 0.076 versus 0.009 +/- 0.011; P < 0.0001). Moreover, high-grade lymphomas showed significantly increased apoptotic rates compared to low-grade cases (5.3 and 1.1% of terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL)-positive cells, respectively; P < 0.0001). In the whole series, the percentage of GrB+ cells and the GrB+/CD20+ ratio showed a strong linear correlation with the number of TUNEL-labeled cells. These findings, together with the frequent colocalization of CTLs and TUNEL+ neoplastic cells, suggested that apoptotic death of lymphoma cells may be due at least in part to the killing by cytotoxic effectors. Our results are consistent with the occurrence of host antitumor cell-mediated immune responses in gastric MALT lymphomas. Moreover, the finding of stronger cytotoxic responses in high- than in low-grade cases is of potential usefulness in the design of more effective therapeutic strategies for the management of these disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487840      PMCID: PMC1866896          DOI: 10.1016/S0002-9440(10)65181-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes.

Authors:  P Anderson; C Nagler-Anderson; C O'Brien; H Levine; S Watkins; H S Slayter; M L Blue; S F Schlossman
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

Review 2.  How do lymphocytes kill tumor cells?

Authors:  T A Graubert; T J Ley
Journal:  Clin Cancer Res       Date:  1996-05       Impact factor: 12.531

Review 3.  Molecular pathways of CTL-mediated cytotoxicity.

Authors:  W R Clark; C M Walsh; A A Glass; F Hayashi; M Matloubian; R Ahmed
Journal:  Immunol Rev       Date:  1995-08       Impact factor: 12.988

Review 4.  Granzymes: exogenous proteinases that induce target cell apoptosis.

Authors:  M J Smyth; J A Trapani
Journal:  Immunol Today       Date:  1995-04

Review 5.  Perforin: structure and function.

Authors:  C C Liu; C M Walsh; J D Young
Journal:  Immunol Today       Date:  1995-04

Review 6.  Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia.

Authors:  M J Blaser; J Parsonnet
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

7.  The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma.

Authors:  M Du; H Peng; N Singh; P G Isaacson; L Pan
Journal:  Blood       Date:  1995-12-15       Impact factor: 22.113

8.  Localization in situ of costimulatory molecules and cytokines in B-cell non-Hodgkin's lymphoma.

Authors:  F A Vyth-Dreese; H Boot; T A Dellemijn; D M Majoor; L C Oomen; J D Laman; M Van Meurs; R A De Weger; D De Jong
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

9.  Helicobacter pylori infection and gastric lymphoma.

Authors:  J Parsonnet; S Hansen; L Rodriguez; A B Gelb; R A Warnke; E Jellum; N Orentreich; J H Vogelman; G D Friedman
Journal:  N Engl J Med       Date:  1994-05-05       Impact factor: 91.245

10.  A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks.

Authors:  A Migheli; P Cavalla; S Marino; D Schiffer
Journal:  J Neuropathol Exp Neurol       Date:  1994-11       Impact factor: 3.685

View more
  3 in total

1.  Expression of CD86 and increased infiltration of NK cells are associated with Helicobacter pylori-dependent state of early stage high-grade gastric MALT lymphoma.

Authors:  Sung-Hsin Kuo; Li-Tzong Chen; Chi-Long Chen; Shin-Lian Doong; Kun-Huei Yeh; Ming-Shiang Wu; Tsui-Lien Mao; Hui-Chen Hsu; Hsiu-Po Wang; Jaw-Town Lin; Ann-Lii Cheng
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

Review 2.  Review of the molecular profile and modern prognostic markers for gastric lymphoma: how do they affect clinical practice?

Authors:  Leonidas Alevizos; Ilias P Gomatos; Spyridon Smparounis; Manousos M Konstadoulakis; Georgios Zografos
Journal:  Can J Surg       Date:  2012-04       Impact factor: 2.089

3.  Fluorescent probes detecting the phagocytic phase of apoptosis: enzyme-substrate complexes of topoisomerase and DNA.

Authors:  Candace L Minchew; Vladimir V Didenko
Journal:  Molecules       Date:  2011-06-03       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.